A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced ...

Doctors share what the findings may mean for the future of cancer treatment.

The Cancer Research Institute launches a first-of-its-kind open-access database to help scientists better understand how the immune system responds to cancer treatments over time. The collaborative ...

DALLAS — One person’s waste could be another’s shot at fighting cancer. The idea may sound far-fetched, but it is gaining ...